During the past decade, Clinica Dermacross S.A. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Dermacross S.A." #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Dermacross S.A." are "Dermatitis, Atopic" (3 trials), "Dermatitis" (2 trials), "Eczema" (2 trials), "Generalized Pustular Psoriasis" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "Clinica Dermacross S.A." in a lesser frequency.

Most popular intervention types in "Clinica Dermacross S.A." are "Drug" (11 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abrocitinib 200 mg" (2 trials), "GDC-0853" (2 trials), "PF-04965842 100 mg" (2 trials) and "PF-04965842 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Dermacross S.A." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Dermacross S.A.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinica Dermacross S.A., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Dermacross S.A., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".